AKBA vs CRON

Head-to-Head Stock Analysis & Investment Rating

Last Updated: Nov 11, 2026

AKBA

56.7
AI Score
VS
AKBA Wins

CRON

49.4
AI Score

Investment Advisor Scores

AKBA

57score
Recommendation
HOLD

CRON

49score
Recommendation
HOLD

AI Analyst Insights

Detailed Metrics Comparison

Metric AKBA CRON Winner
Forward P/E 28.7356 22.3714 CRON
PEG Ratio 0 0 Tie
Revenue Growth -37.2% 74.6% CRON
Earnings Growth 0.0% -41.0% AKBA
Tradestie Score 56.7/100 49.4/100 AKBA
Profit Margin -22.6% 28.0% CRON
Beta 1.00 1.00 Tie
AI Recommendation HOLD HOLD Tie

Relative Price Performance (Last 90 Days)

AKBA 1M: -31.8% · 3M: -44.9% CRON 1M: +5.6% · 3M: +7.3%

Current Technical Phase

AKBA

Markdown
Sell / avoid

Price below a falling SMA50 (slope -13.4%), weak momentum, RSI 37

RSI (14): 36.5 · Price: $0.47

CRON

Neutral
Hold

Mixed signals - no dominant trend phase, RSI 50

RSI (14): 49.6 · Price: $3.38

Fundamentals Snapshot

Metric AKBA CRON
Market Cap — —
Forward P/E -1.4 13.3
Trailing P/E — 21.3
Revenue (TTM) — —
Revenue Growth -0.4% 0.7%
Gross Margin 0.8% 0.5%
Operating Margin -0.1% 0.1%
EPS -0.17 0.16
Dividend Yield — —

Frequently Asked Questions

Based on our detailed analysis, AKBA is currently the stronger investment candidate based on our comprehensive scoring model.

We analyze revenue and earnings growth rates in the "Growth" section above. Generally, the company with higher year-over-year revenue and EPS growth is fostering better expansion. Check the table above for the specific growth percentages.

Valuation is determined by metrics like the P/E Ratio and PEG Ratio. A lower P/E typically suggests a stock is cheaper relative to its earnings. Refer to the "Valuation" section in our comparison table to see which stock currently trades at a more attractive multiple.